59.02MMarket Cap-656P/E (TTM)
7.4300High6.2300Low34.58KVolume7.2500Open7.2500Pre Close236.56KTurnover0.58%Turnover RatioLossP/E (Static)9.37MShares10.700052wk High5.13P/B37.85MFloat Cap1.860052wk Low--Dividend TTM6.01MShs Float3939.6222Historical High--Div YieldTTM16.55%Amplitude1.8600Historical Low6.8410Avg Price1Lot Size
Benitec Biopharma Stock Forum
NEWS
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Positive interim clinical trial data for the first OPMD subject treated with BB-301 in a Phase 1b/2a study
Improvements in swallowing function demonstrated in multiple measures following BB-301 administration
No serious adverse events reported, with transient GERD resolved with common medications
Encouraging early clinical trial result...
open an finance,s account svp merci eih....
We're seeking community insights on the potential movement of this stock in the coming one to two months. Do you anticipate it to rise or fall?
If you have any solid ideas, insider information, or news that might influence this stock's direction, kindly share in the comments section below. Your input is greatly valued!
Thank you for your participation.
$Benitec Biopharma(BNTC.US)$
No comment yet